文献速递腹部CT

小偶然发现的不确定性低密度肝脏病灶的特征描述:单期增强双能CT物质衰减分析的附加价值

Characterization of Small Incidental Indeterminate Hypoattenuating Hepatic Lesions: Added Value of Single-Phase Contrast-Enhanced Dual-Energy CT Material Attenuation Analysis.
PubMed 文献 · AJR Am J Roentgenol · 2018-07-24

回顾性分析55例患者77个0.5-2.0 cm低密度肝病灶,比较单期增强双能CT碘定量与传统混合120 kVp图像及对比图对病灶的鉴别效能;碘浓度阈值1.2±0.1 mg I/mL鉴别良恶性敏感度0.94、特异度0.93、AUC 0.97,优于混合图像和对比图。

要点

  • 小低密度肝病灶碘浓度阈值1.2±0.1 mg I/mL,敏感度0.94、特异度0.93、AUC 0.97。
  • 混合120 kVp图像最佳阈值50.2±5.2 HU,敏感度0.89、特异度0.70、AUC 0.81。
  • 对比图最佳阈值11.5±2.0 HU,敏感度0.94、特异度0.64、AUC 0.77。

核心结论

  • 单期增强双能CT物质衰减图像碘定量相比常规衰减测量,改善小(<2 cm)偶然发现不确定性低密度肝病灶的良恶性鉴别。

研究设计与样本

  • 回顾性研究,55例患者(24男31女,平均年龄63.9±15.3岁)共77个偶然发现低密度肝病灶(59良性、18恶性),病灶大小0.5-2.0 cm,因腹痛行单期增强腹部双能CT。

诊断标准与关键数值

  • 碘浓度鉴别良恶性最佳阈值1.2±0.1 mg I/mL,敏感度0.94、特异度0.93、AUC 0.97;混合120 kVp图像最佳衰减阈值50.2±5.2 HU,敏感度0.89、特异度0.70、AUC 0.81;对比图最佳衰减阈值11.5±2.0 HU,敏感度0.94、特异度0.64、AUC 0.77。

临床应用与阅片要点

  • 对<2 cm的偶然发现低密度肝病灶,可测量碘浓度并以1.2±0.1 mg I/mL为鉴别阈值,其诊断效能优于混合120 kVp图像和对比图衰减测量。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: The objective of this study is to determine whether single-phase contrast-enhanced dual-energy CT (DECT) material attenuation analysis improves the characterization of small (< 2.0 cm) incidental indeterminate hypoattenuating hepatic lesions, compared with conventional single-energy CT evaluation.

MATERIALS AND METHODS: This retrospective study involved 55 patients (24 men and 31 women; mean [± SD] age, 63.9 ± 15.3 years) with 77 incidental hypoattenuating hepatic lesions (59 benign and 18 malignant lesions) measuring 0.5-2.0 cm who underwent single-phase contrast-enhanced DECT of the abdomen for pain. For each lesion, attenuation measurements were obtained using blended 120-kVp-equivalent images and contrast map images. DECT material attenuation images were used for iodine quantification. Optimal lesion attenuation and iodine concentration threshold values that best distinguished benign lesions from malignant lesions were generated using smooth bootstrapping. The diagnostic accuracy of the optimized thresholds was compared using the Wilcox rank sum test.

RESULTS: The optimal mean (± standard error) attenuation threshold values that best differentiated benign and malignant lesions were 50.2 ± 5.2 HU and 11.5 ± 2.0 HU when blended 120-kVp and contrast map images, respectively, were used. The iodine concentration (expressed as milligrams of iodine per milliliter) differed significantly (p < 0.0001) between benign lesions (0.6 ± 0.4 mg I/mL) and malignant lesions (1.7 ± 0.4 mg I/mL). The optimal iodine concentration that best distinguished between benign and malignant lesions was 1.2 ± 0.1 mg I/mL. The sensitivity, specificity, and AUC value were highest for iodine concentration (0.94, 0.93, and 0.97, respectively), compared with blended images (0.89, 0.70, and 0.81, respectively) and contrast map images (0.94, 0.64, 0.77, respectively).

CONCLUSION: Iodine quantification performed using single-phase contrast-enhanced DECT material attenuation images improves the characterization of small (< 2 cm) incidental indeterminate hypoattenuating hepatic lesions, compared with conventional attenuation measurements.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Patel BN, Rosenberg M, Vernuccio F, et al. Characterization of Small Incidental Indeterminate Hypoattenuating Hepatic Lesions: Added Value of Single-Phase Contrast-Enhanced Dual-Energy CT Material Attenuation Analysis. AJR Am J Roentgenol. 2018. PMID: 30040464. doi:10.2214/AJR.17.19170

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。